ERBB2 and neoplasm: These factors include the stage of the disease, nodal status, tumor size, tumor grade, type of tumor, tumor histology, the number of involved nodes, the presence of lymphatic or vascular invasion, hormone receptor status, human epidermal growth factor receptor 2 status, the Nottingham Prognostic Index (NPI), and age [5,7-13].